Table 1. Demographic and clinical characteristics.
| Individuals with PD and FOG (n = 32) | |
|---|---|
| Sex (F/M) | 9/23 |
| Age (years) | 65.13 (61.78, 68.47) |
| Body Mass (kg) | 76.72 (68.57, 83.87) |
| Height (cm) | 164 (160, 168) |
| Time of disease (years) | 9.19 (7.35, 11.04) |
| MMSE | 26.55 (25.24, 27.86) |
| FOG-Q | 13.97 (12.20, 15.74) |
| H&Y (off) | |
| 1 / 1.5 / 2 / 2.5 | 1 / 1 / 4 / 6 |
| 3 / 4 | 11 / 8 |
| 5 | 1 |
| H&Y (on) | |
| 1 / 1.5 / 2 / 2.5 | 6 / 5 / 4 / 9 |
| 3 / 4 | 5 / 3 |
| 5 | 0 |
| UPDRS III (off) | 23.97 (20.83, 27.11) |
| UPDRS III (on) | 11.00 (11.63, 15.79) |
| LEDD (mg) | 1044 (867, 1232) |
Note. Data are mean and 95% confidence intervals (lower bound, upper bound). H&Y and sex are in frequencies.
Abbreviations: PD: Parkinson disease; FOG: Freezing of gait; MMSE: Mini mental state examination; FOG-Q: Freezing of gait questionnaire; H&Y (off): Modified Hoehn & Yahr scale during off-medication state; UPDRS III (off): Motor part of the Unified Parkinson’s disease rating scale during off-medication state; LEDD: Levodopa equivalent daily medication dosage [31].